BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21423200)

  • 21. Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing.
    Simmons DP; Wearsch PA; Canaday DH; Meyerson HJ; Liu YC; Wang Y; Boom WH; Harding CV
    J Immunol; 2012 Apr; 188(7):3116-26. PubMed ID: 22371391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation.
    Qian C; An H; Yu Y; Liu S; Cao X
    Blood; 2007 Apr; 109(8):3308-15. PubMed ID: 17170125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD34-derived human Langerhans cells stimulate a T helper type 2 response independently of extracellular-signal-regulated kinase phosphorylation.
    Duraisingham SS; Hornig J; Gotch F; Patterson S
    Immunology; 2010 Oct; 131(2):210-9. PubMed ID: 20465567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells.
    Mennechet FJ; Uzé G
    Blood; 2006 Jun; 107(11):4417-23. PubMed ID: 16478884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
    Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
    J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.
    Luft T; Luetjens P; Hochrein H; Toy T; Masterman KA; Rizkalla M; Maliszewski C; Shortman K; Cebon J; Maraskovsky E
    Int Immunol; 2002 Apr; 14(4):367-80. PubMed ID: 11934873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCs.
    Avril T; de Tayrac M; Leberre C; Quillien V
    J Immunother; 2009 May; 32(4):353-62. PubMed ID: 19342970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
    Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
    Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
    J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
    Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
    J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions.
    Peng JC; Hyde C; Pai S; O'Sullivan BJ; Nielsen LK; Thomas R
    J Immunother; 2006; 29(6):606-15. PubMed ID: 17063123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIMP1/p43 protein induces the maturation of bone marrow-derived dendritic cells with T helper type 1-polarizing ability.
    Kim E; Kim SH; Kim S; Cho D; Kim TS
    J Immunol; 2008 Mar; 180(5):2894-902. PubMed ID: 18292511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal Dendritic Cells Are Altered in Number, Maturity and Chemotactic Ability in Fulminant Hepatic Failure.
    Liu M; Wang P; Zhao M; Liu DY
    PLoS One; 2016; 11(11):e0166165. PubMed ID: 27832135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells differentiated in the presence of a single-stranded viral RNA sequence conserve their ability to activate CD4 T lymphocytes but lose their capacity for Th1 polarization.
    Marin-Esteban V; Abdul M; Charron D; Haziot A; Mooney N
    Clin Vaccine Immunol; 2008 Jun; 15(6):954-62. PubMed ID: 18400975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.
    Chen XZ; Mao XH; Zhu KJ; Jin N; Ye J; Cen JP; Zhou Q; Cheng H
    Arch Dermatol Res; 2010 Jan; 302(1):57-65. PubMed ID: 19578865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells.
    Farkas A; Tonel G; Nestle FO
    Br J Dermatol; 2008 May; 158(5):921-9. PubMed ID: 18371115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-gamma-mediated signaling.
    Heystek HC; den Drijver B; Kapsenberg ML; van Lier RA; de Jong EC
    Clin Immunol; 2003 Jun; 107(3):170-7. PubMed ID: 12804530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lys-des[Arg9]-bradykinin alters migration and production of interleukin-12 in monocyte-derived dendritic cells.
    Gulliver R; Baltic S; Misso NL; Bertram CM; Thompson PJ; Fogel-Petrovic M
    Am J Respir Cell Mol Biol; 2011 Sep; 45(3):542-9. PubMed ID: 21177981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.
    Mailliard RB; Wankowicz-Kalinska A; Cai Q; Wesa A; Hilkens CM; Kapsenberg ML; Kirkwood JM; Storkus WJ; Kalinski P
    Cancer Res; 2004 Sep; 64(17):5934-7. PubMed ID: 15342370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.